Michael Schwartz

Life sciences entrepreneur and product marketing professional

[Michael Schwartz @Mike_Schwartz1]

Excited to join 20/15 Visioneers again on Jun 20 for a session focused on biopharma process development. The advent of modern, complex drug architectures has created new need to evolve process informatics ... looking forward to the…https://t.co/ojnLVdcd4d https://t.co/GFKhVJAiA5

[Michael Schwartz @Mike_Schwartz1]

Benchling's PoV on what Customer Success means in the world of biotech R&D, from our new Head of Global Customer Success, Clare Urlich https://t.co/8KUV8taBog

[Michael Schwartz @Mike_Schwartz1]

Very excited for this launch. We’re introducing a full range of solutions, services, and product innovations to help accelerate R&D for our biotech customers. Learn more at our What’s New webinar Apr 4. https://t.co/Exmv7X3rZg

[Michael Schwartz @Mike_Schwartz1]

Some exciting new roles at Benchling ... like this one. If you have solid BD experience building and running a partner ecosystem, feel free to apply or reach out. https://t.co/VHzqmySim5

[Michael Schwartz @Mike_Schwartz1]

Excited for this upcoming conversation with Darren W Begley. Tune in to hear his expertise and advice covering the intersection of analytical science, emerging therapeutics, and R&D informatics, and bring your own ?'s too. https://t.co/2bRCNd9K1f

[Michael Schwartz @Mike_Schwartz1]

Excited to hook up with Genetic Engineering & Biotechnology News for this session on cell and gene therapy R&D, featuring @Davegkugler from Cartography Biosciences and Zachary Reinert from Benchling. Lots of experience to learn from here! https://t.co/f05HsVPwcx

[Michael Schwartz @Mike_Schwartz1]

In vivo studies are the critical link between innovative bench science and clinical programs. It was a pleasure to sit down with our customers across 3 global #Benchtalk events to discuss this critical area of biotech R&D, and this…https://t.co/hN3YheiGwz https://t.co/ouuJ0kF3BS

[Michael Schwartz @Mike_Schwartz1]

An inspiring week for me across two Light the Night events in SF and East Bay ... so many stories of hope, but much work left to be done. Thanks to The Leukemia & Lymphoma Society for fighting the good fight here on behalf of patients and their families! https://t.co/ayHUCMQMh0

[Michael Schwartz @Mike_Schwartz1]

It's been a minute since I've reached out for fundraising for the The Leukemia & Lymphoma Society (those who supported my #TeamInTraining Ironman Canada adventure - will never forget ya). But proud to be supporting #lightthenight w…https://t.co/JBeGyz9l29 https://t.co/eKLMZGt7W7

[Michael Schwartz @Mike_Schwartz1]

Benchling is proud to support #LightTheNight as we help raise awareness and funds for research — all in celebration and honor of the patients and families impacted by blood cancers. Support our team here: https://t.co/6NKiLFVPyl

[Michael Schwartz @Mike_Schwartz1]

A new generation of biologics is being discovered and developed, faster than ever before. Happy to share some learnings from working with hundreds of antibody and protein innovators in this infographic. https://t.co/y7hkN4EWpe

[Michael Schwartz @Mike_Schwartz1]

#Benchtalk is back! This summer, join us in San Francisco, Zürich, or Boston for @benchling's annual industry event for life science innovators, where you can learn, engage, and hang out with other folks in #biotechnology. Register now: https://t.co/K8ORTrk7Mn

[Michael Schwartz @Mike_Schwartz1]

Cell and gene therapies have shown tremendous potential on multiple fronts ... using the immune system to attack cancer, curing rare/monogenic diseases, and bringing new tools to other difficult to treat conditions. But tracking th…https://t.co/rqV4Oq29Fc https://t.co/X2E3wKcHCR

[Michael Schwartz @Mike_Schwartz1]

Amazing what the team at Bolt Threads has been able to accomplish ... innovation and execution on a vision for sustainable biomaterials. Can't wait to grab a pair of Adidas kicks for myself! https://t.co/w736KyS0mm

[Michael Schwartz @Mike_Schwartz1]

Proud to see @benchling on the 2022 #EnterpriseTech30 list! 🏆 The #ET30 list recognizes companies with the most potential to meaningfully shift how tech enterprises operate for the better.

[Michael Schwartz @Mike_Schwartz1]

https://t.co/BMjPFayJ2c

[Michael Schwartz @Mike_Schwartz1]

https://t.co/e27RwoEm2a

[Michael Schwartz @Mike_Schwartz1]

It was another prolific year for Benchling's Product and Engineering teams ... delivering new capabilities into the R&D Cloud that help our customers unlock the power of biotechnology. Catch up on what's new: https://t.co/WL7yZ1AfwM https://t.co/QxTS50A5gl

[Michael Schwartz @Mike_Schwartz1]

An exciting new role open at Benchling ... puts you in a front row seat to every new launch and initiative. You'd work with some incredible industry execs (e.g. @roopal1021) and cross-functional teams. If you have strong GTM drive and always sweat the det…https://t.co/sY3MdPcctm